Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

Author:

Saag Michael S.1,Gandhi Rajesh T.2,Hoy Jennifer F.3,Landovitz Raphael J.4,Thompson Melanie A.5,Sax Paul E.6,Smith Davey M.7,Benson Constance A.7,Buchbinder Susan P.8,del Rio Carlos9,Eron Joseph J.10,Fätkenheuer Gerd11,Günthard Huldrych F.12,Molina Jean-Michel13,Jacobsen Donna M.14,Volberding Paul A.15

Affiliation:

1. University of Alabama at Birmingham

2. Harvard Medical School and Massachusetts General Hospital, Boston

3. Monash University and Alfred Hospital, Melbourne, Australia

4. University of California, Los Angeles

5. AIDS Research Consortium of Atlanta, Atlanta, Georgia

6. Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts

7. University of California, San Diego, La Jolla

8. San Francisco Department of Public Health and University of California, San Francisco

9. Emory University School of Medicine, Atlanta, Georgia

10. School of Medicine, University of North Carolina, Chapel Hill

11. University Hospital Cologne, Cologne, Germany

12. University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland

13. University of Paris and Saint-Louis/Lariboisière Hospitals, APHP, Paris, France

14. International Antiviral Society–USA, San Francisco, California

15. University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference98 articles.

1. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA panel.;Saag;JAMA,2018

2. The periodic health examination.;Canadian Task Force on the Periodic Health Examination;Can Med Assoc J,1979

3. Rapid initiation of antiretroviral therapy for people living with HIV.;Mateo-Urdiales;Cochrane Database Syst Rev,2019

4. Engagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trial.;Amstutz;Clin Infec Dis

5. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.;Coffey;AIDS,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3